je.st
news
Home
› SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies
SK Biopharmaceuticals Announces A Strategic Alliance For Innovative Drug Development With Chinese Biopharmaceutical Companies
2013-03-27 14:56:00| drugdiscoveryonline News Articles
The South Korean pharmaceutical company, SK Biopharmaceuticals, announced that they entered into a collaboration agreement with PKU International HealthCare Group, China, and Shanghai Medicilon, China, for its novel new small molecule SKL-PSY that is being developed for the treatment of depression and bipolar disorder
Tags: development
companies
chinese
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||